Clinical Trials – Multi Site

By: | Tags: , , | Comments: 0 | July 18th, 2014

BioMark is proud to partner and cooperate with National Cancer Institute in Bangladesh and BioMark China in a phase III multi site trial. The trail will involve over 400 subjects and will focus on 4 cancer indications. All the procedures will follow North American regulatory guidelines that were prepared by Saint Boniface Research centre’s regulatory group.

You must be logged in to post a comment.